Literature DB >> 2785045

Permanent alteration of the murine Ly-1 B repertoire due to selective depletion of Ly-1 B cells in neonatal animals.

P A Lalor1, A M Stall, S Adams, L A Herzenberg.   

Abstract

Studies presented here demonstrate that paternal allotype Ly-1 B cells are permanently depleted following neonatal treatment with antibodies to the paternal IgM allotype. Paternal allotype conventional B cells, in contrast, are temporarily depleted by treatment with either anti-IgM or anti-IgD allotype antibodies and return rapidly to normal frequencies once the antibody treatment disappears. These differences are explained by basic developmental differences between Ly-1 B and conventional lineage B cells. That is, the conventional B cell population is replenished from Ig- precursors throughout life and, therefore, is only temporarily affected when depleted in neonates. The Ly-1 B cell population, in contrast, develops from Ig- progenitors during the prenatal and neonatal life but survives because it is exclusively self-replenishing in adults. Therefore, elimination of a population of Ly-1 B cells from neonates is tantamount to removing it forever. These findings suggest that while conventional B cells turn over rapidly and have an effectively unlimited repertoire, Ly-1 B cells express a repertoire whose composition is strongly influenced by neonatal conditions that favor or select against the retention of cells producing certain antibody molecules. Thus, Ly-1 B cells play a unique role in the immune system in that they retain indefinitely the history of the neonatal animal's immunological experience.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785045     DOI: 10.1002/eji.1830190314

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

1.  CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools.

Authors:  N Baumgarth; G C Jager; O C Herman; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

Review 3.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.

Authors:  Nicole Baumgarth; James W Tung; Leonore A Herzenberg
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

4.  Differential development of progenitor activity for three B-cell lineages.

Authors:  A B Kantor; A M Stall; S Adams; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

5.  At the crossroads between tolerance and aggression: Revisiting the "layered immune system" hypothesis.

Authors:  Jeff E Mold; Joseph M McCune
Journal:  Chimerism       Date:  2011-04

Review 6.  Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease.

Authors:  Trevor D Burt
Journal:  Am J Reprod Immunol       Date:  2013-02-25       Impact factor: 3.886

Review 7.  B cells and atherosclerosis.

Authors:  Prasad Srikakulapu; Coleen A McNamara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

8.  Natural and induced B-1 cell immunity to infections raises questions of nature versus nurture.

Authors:  Nicole Baumgarth; Elizabeth E Waffarn; Trang T T Nguyen
Journal:  Ann N Y Acad Sci       Date:  2015-06-09       Impact factor: 5.691

9.  B-1-like cells exist in sheep. Characterization of their phenotype and behaviour.

Authors:  N Chevallier; M Berthelemy; V Lainé; D Le Rhun; F Féménia; B Polack; J Naessens; D Levy; I Schwartz-Cornil
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

Review 10.  Bone marrow fat and the decline of B lymphopoiesis in rabbits.

Authors:  Domenick E Kennedy; Pamela L Witte; Katherine L Knight
Journal:  Dev Comp Immunol       Date:  2015-11-11       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.